Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia

• Carolina Vázquez ,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: carolina.vazquez@hospitalitaliano.org.ar

  Affiliations A.R.G Argentine Rendu Study Group, Buenos Aires, Argentina, Internal Medicine Department, Hospital Italiano, Buenos Aires, Argentina

  http://orcid.org/0000-0003-2834-9047

  ⨯
• María Laura Gonzalez,

  Roles Data curation, Methodology, Writing – review & editing

  Affiliations A.R.G Argentine Rendu Study Group, Buenos Aires, Argentina, Hereditary Hemorrhagic Telangiectasia Unit, Hospital Italiano, Buenos Aires, Argentina, Gastroenterology Department, Hospital Italiano, Buenos Aires, Argentina

  ⨯
• Augusto Ferraris,

  Roles Data curation, Methodology, Writing – review & editing

  Affiliations A.R.G Argentine Rendu Study Group, Buenos Aires, Argentina, Internal Medicine Department, Hospital Italiano, Buenos Aires, Argentina

  ⨯
• Juan Carlos Bandi,

  Roles Supervision, Validation, Writing – review & editing

  Affiliations A.R.G Argentine Rendu Study Group, Buenos Aires, Argentina, Hereditary Hemorrhagic Telangiectasia Unit, Hospital Italiano, Buenos Aires, Argentina, Hepatology Department, Hospital Italiano, Buenos Aires, Argentina

  ⨯
• Marcelo Martín Serra

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Supervision, Writing – review & editing

  Affiliations A.R.G Argentine Rendu Study Group, Buenos Aires, Argentina, Internal Medicine Department, Hospital Italiano, Buenos Aires, Argentina, Hereditary Hemorrhagic Telangiectasia Unit, Hospital Italiano, Buenos Aires, Argentina

  http://orcid.org/0000-0002-9912-9503

  ⨯